Document is current
Any future updates will be listed below
-
Authors
Buqué, Aitziber
Beltrán-Visiedo, Manuel https://orcid.org/0000-0002-7977-8020
Sato, Ai
Galassi, Claudia
Petroni, Giulia
Galluzzi, Lorenzo https://orcid.org/0000-0003-2257-8500
- License Information
-
More Information
Article History
Received: 19 March 2025
Revised: 16 May 2025
Accepted: 30 May 2025
First Online: 10 June 2025
Competing interests
: LG is/has been holding research contracts with Lytix Biopharma, Promontory, and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. All other authors have no conflicts to declare.
